Allogene Therapeutics, Inc. Uncategorized Contracts & Agreements
2 Contracts & Agreements
- Form of Indemnity Agreement by and between the Registrant and its directors and officers (Filed With SEC on October 2, 2018)
- Option for Rights to Retained Territory Letter Agreement, dated April 2, 2018, by and between the Registrant and Pfizer Inc (Filed With SEC on September 14, 2018)
